1 – 10 of 10
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Discovery and Structural Characterization of a Phospholamban-Binding Cyclic Peptide and Design of Novel Inhibitors of Phospholamban
(
- Contribution to journal › Article
- 2012
-
Mark
Method for the prevention of thromboembolic disorders
2012) US 08329693(
- Patent › Patent
-
Mark
Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Compounds for deactivating phospholamban function on Ca-ATPase (phospholamban inhibitors)
2004) US 6774103 B1(
- Patent › Patent
- 2001
-
Mark
Binding of Levosimendan, a Calcium Sensitizer, to Cardiac Troponin C
(
- Contribution to journal › Article
-
Mark
Phospholamban inhibitors and a method for increasing coronary flow
2001) US 6265421(
- Patent › Patent
- 2000
-
Mark
Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan : Structure-response and binding analysis with analogs of levosimendan
(
- Contribution to journal › Article
-
Mark
Conformations of the regulatory domain of cardiac troponin C examined by residual dipolar couplings
(
- Contribution to journal › Article
- 1998
-
Mark
Solution structure and main chain dynamics of the regulatory domain (Residues 1-91) of human cardiac troponin C
(
- Contribution to journal › Article
- 1994
-
Mark
Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C : A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study
(
- Contribution to journal › Article